Literature DB >> 19655425

Growth promotion and cell binding ability of bovine lactoferrin to Bifidobacterium longum.

Md Morshedur Rahman1, Woan-Sub Kim, Toshiaki Ito, Haruto Kumura, Kei-ichi Shimazaki.   

Abstract

Lactoferrin, a major whey protein of human milk, is considered as growth promoter for bifidobacteria, the predominant microorganisms of human intestine. In the present study, in vitro growth promotion and cell binding ability of bovine lactoferrin to several strains of Bifidobacterium longum have been demonstrated. A dose-dependent as well as strain-dependent growth promotion effect by lactoferrin was observed. Cell binding ability of lactoferrin was inspected under an inverted confocal laser scanning microscope by incubation bacterial cells with biotinylated bovine lactoferrin and FITC-conjugated avidin. Fluorescence staining showed bovine lactoferrin binding to all tested strains. A lactoferrin-binding protein with a molecular weight of approximately 67 kDa was also detected in the extracted membrane and cytosolic fraction of each B. longum strain by far-Western blot technique using biotinylated lactoferrin and horseradish peroxidase-conjugated streptavidin. Based on these results, we suggest that existence of lactoferrin-binding protein could be a common characteristic in bifidobacteria. It can also be hypothesized that lactoferrin-binding protein in bifidobacteria is not only involved in growth stimulation mechanism but also could play different roles.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19655425     DOI: 10.1016/j.anaerobe.2009.01.003

Source DB:  PubMed          Journal:  Anaerobe        ISSN: 1075-9964            Impact factor:   3.331


  16 in total

1.  Endo-β-N-acetylglucosaminidases from infant gut-associated bifidobacteria release complex N-glycans from human milk glycoproteins.

Authors:  Daniel Garrido; Charles Nwosu; Santiago Ruiz-Moyano; Danielle Aldredge; J Bruce German; Carlito B Lebrilla; David A Mills
Journal:  Mol Cell Proteomics       Date:  2012-06-27       Impact factor: 5.911

Review 2.  New concepts of microbial translocation in the neonatal intestine: mechanisms and prevention.

Authors:  Michael P Sherman
Journal:  Clin Perinatol       Date:  2010-09       Impact factor: 3.430

Review 3.  The impact of the milk glycobiome on the neonate gut microbiota.

Authors:  Alline R Pacheco; Daniela Barile; Mark A Underwood; David A Mills
Journal:  Annu Rev Anim Biosci       Date:  2014-11-05       Impact factor: 8.923

4.  Intestinal Epithelial Barrier Function and Necrotizing Enterocolitis.

Authors:  Elizabeth Managlia; Xiaocai Yan; Isabelle G De Plaen
Journal:  Newborn (Clarksville)       Date:  2022-03-31

5.  The Lacuna Trial: a double-blind randomized controlled pilot trial of lactoferrin supplementation in the very preterm infant.

Authors:  K J Barrington; M-A Assaad; A Janvier
Journal:  J Perinatol       Date:  2016-03-03       Impact factor: 2.521

Review 6.  Milk Glycans and Their Interaction with the Infant-Gut Microbiota.

Authors:  Nina Kirmiz; Randall C Robinson; Ishita M Shah; Daniela Barile; David A Mills
Journal:  Annu Rev Food Sci Technol       Date:  2018-03-25

Review 7.  Host-microbe interactions in the neonatal intestine: role of human milk oligosaccharides.

Authors:  Sharon M Donovan; Mei Wang; Min Li; Iddo Friedberg; Scott L Schwartz; Robert S Chapkin
Journal:  Adv Nutr       Date:  2012-05-01       Impact factor: 8.701

8.  C-lobe of lactoferrin: the whole story of the half-molecule.

Authors:  Sujata Sharma; Mau Sinha; Sanket Kaushik; Punit Kaur; Tej P Singh
Journal:  Biochem Res Int       Date:  2013-05-15

9.  Intestinal microbiota, probiotics and mental health: from Metchnikoff to modern advances: Part II - contemporary contextual research.

Authors:  Alison C Bested; Alan C Logan; Eva M Selhub
Journal:  Gut Pathog       Date:  2013-03-14       Impact factor: 4.181

10.  Oropharyngeal administration of mother's colostrum, health outcomes of premature infants: study protocol for a randomized controlled trial.

Authors:  Nancy A Rodriguez; Maximo Vento; Erika C Claud; Chihsiung E Wang; Michael S Caplan
Journal:  Trials       Date:  2015-10-12       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.